Company Filing History:
Years Active: 2020-2022
Title: Byungji Kim: Innovator in Nanoparticle Technology
Introduction
Byungji Kim is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of nanoparticle technology, particularly in the development of innovative delivery systems for therapeutic applications. With a total of 2 patents, his work focuses on enhancing the efficiency of drug delivery mechanisms.
Latest Patents
One of Byungji Kim's latest patents involves fusogenic liposome-coated porous silicon nanoparticles. This invention describes a system designed for high loading efficiency of anionic payloads, including small molecules, dyes, and nucleic acids. The technology allows for non-endocytic delivery of both hydrophilic and lipophilic payloads through membrane fusion. The liposome coating can be modified with targeting peptides or antibodies, utilizing covalent binding chemistry with functionalized poly(ethylene glycol). This innovative approach enables the transfer of surface moieties to cellular membranes via fusogenic uptake, making it applicable in the treatment of various diseases by delivering encapsulated payloads.
Career Highlights
Byungji Kim is affiliated with the University of California, where he continues to advance research in nanoparticle technology. His work has garnered attention for its potential applications in medical treatments and drug delivery systems.
Collaborations
Some of his notable coworkers include Michael J Sailor and Jinyoung Kang, who have contributed to the research and development of his innovative technologies.
Conclusion
Byungji Kim's contributions to nanoparticle technology and drug delivery systems highlight his role as a leading inventor in the field. His innovative approaches have the potential to significantly impact medical treatments and improve patient outcomes.